Register Cart 0

Generic placeholder image

Current Radiopharmaceuticals

Editor-in-Chief

ISSN (Print): 1874-4710
ISSN (Online): 1874-4729

Back Subscribe

Editorial

Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment)

Author(s): Ambikalmajan M.R. Pillai and Furn F. (Russ) Knapp

Volume 9, Issue 1, 2016

Page: [6 - 7] Pages: 2

DOI: 10.2174/187447100901151123124826

Price: $65

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

69

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Isolation, Purification and Characterization of a Novel Steroidal Saponin Cholestanol Glucoside from Lasiodiplodia theobromae that Induces Apoptosis in A549 Cells
Anti-Cancer Agents in Medicinal Chemistry

Comparison of Radiohaloanalogues of Meta-Iodobenzylguanidine (MIBG) for a Combined Gene- and Targeted Radiotherapy Approach to Bladder Carcinoma
Medicinal Chemistry

Rexinoids for Prevention and Treatment of Cancer: Opportunities and Challenges
Current Topics in Medicinal Chemistry

Prostate Cancer Immunotherapy: An Evolving Field
Current Cancer Therapy Reviews

Chip-Based High Throughput Screening of Herbal Medicines
Combinatorial Chemistry & High Throughput Screening

Inhibitors of 11β-Hydroxylase (CYP11B1) for Treating Diseases Related to Excess Cortisol
Current Medicinal Chemistry

Application of Monoclonal Antibodies as Cancer Therapy in Solid Tumors
Current Clinical Pharmacology

Anti-inflammatory Phytochemicals for Chemoprevention of Colon Cancer
Current Cancer Drug Targets

Testicular Cell Junction: A Novel Target for Male Contraception
Current Medicinal Chemistry

Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment
Current Signal Transduction Therapy

Cytosine Methyltransferases as Tumor Markers
Current Genomics

Identification of KEY lncRNAs and mRNAs Associated with Oral Squamous Cell Carcinoma Progression
Current Bioinformatics

Pyridine Based Antitumour Compounds Acting at the Colchicine Site
Current Medicinal Chemistry

Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk
Current Medicinal Chemistry

“Virostatics” as a Potential New Class of HIV Drugs
Current Pharmaceutical Design

Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
Current Cancer Drug Targets

The Zinc Metallopeptidase Family: New Faces, New Functions
Protein & Peptide Letters

uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy
Current Drug Targets

Integrin αvβ3 Antagonists for Anti-Angiogenic Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery

NPY Signalling Pathway in Bone Homeostasis: Y1 Receptor as a Potential Drug Target
Current Drug Targets

© 2024 Bentham Science Publishers | Privacy Policy